Lipid monolayers adsorbing mRNA as models for mRNA enclosed in lipid nanoparticles for transfection
Miriam GravaiD, Konrad Weber, Joshua ReediD, Benjamin Weber, Chen Chao SheniD, Heinrich HaasiD, Emanuel SchneckiD
Abstract
In lipid-based mRNA pharmaceuticals applicable for vaccination, cancer therapy, and other types of therapeutics, the negatively charged RNA is embedded in nanoparticles containing positively charged or ionizable lipids. The local cohesion at the lipid-RNA interface plays an important role for the stability and biological activity of the resulting nanoparticles. Ions and other buffer components in the RNAs immediate surroundings may affect RNA stability against hydrolysis and its binding strength to the oppositely charged lipid layers, which is relevant for release after cellular uptake and endosomal processing. Here, we use Langmuir monolayers at the air/water interface as well-defined experimental models to study the local molecular organization of mRNA adsorbed to lipid layers. Binding of mRNA in the presence of monovalent and divalent ions from the aqueous phase to monolayers consisting of cationic transfection lipids and zwitterionic phospholipids is investigated with synchrotron-based x-ray fluorescence and scattering techniques. The experiments provide detailed insights into the structure of the adsorbed layers as well as the fractions of all molecular moieties contributing to the interfacial electrostatic balance, specifically phosphates from RNA, phosphates from phospholipids in the monolayer, and elemental counterions. The mRNA forms discrete electron-dense layers tightly bound to the lipid membrane, where cationic ions accumulate at the interface together with the mRNA. This leads to an excess of anionic nucleotides relative to cationic lipids at the interface, which is more pronounced in the presence of divalent compared to monovalent cations. The quantitative information on local interfacial moieties obtained here may constitute a valuable basis for the evaluation of quality aspects of nanoparticles comprising mRNA in the bulk phase.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 28%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dual Ethanolamine Head Groups in Ionizable Lipids Facilitate Phospholipid-free Stable Nanoparticle Formulation for Augmented and Safer mRNA Delivery
- Rational Design of Unsaturated, Thioether Ionizable Lipids for Enhanced In vivo mRNA Delivery
Eleni Samaridou, Johanna Simon, … Pavel A. Levkin·Advanced Healthcare MaterialsPeer-reviewed·May 5, 2025
- Structural Characterization of mRNA Lipid Nanoparticles in the Presence of Intrinsic Drug-free Lipid Nanoparticles
Xiaoxia Chen, Yongfeng Ye, … Zhuo Liu·Journal of Controlled ReleasePeer-reviewed·Jul 31, 2025
- Lipid nanoparticle shape and morphology determine the magnitude and duration of mRNA transfection
Sara Elsafy, Martin Dulle, … Alexandros Marios Sofias·bioRxiv·Oct 22, 2026
- Buffer specificity of ionizable lipid nanoparticle transfection efficiency and bulk phase transition
Cristina Carucci, Julian Philipp, … Joachim Oskar Rädler·ACS NanoPeer-reviewed·Mar 12, 2025
- Post-loading ribonucleic acid into lipid nanoparticle carriers
Navid Bizmark, David F. Amelemah, … Robert K. Prud’homme·bioRxiv·Jul 22, 2026